1. Osobennosti techeniya beremennosti, rodov, poslerodovogo perioda i sostoyaniya novorozhdennykh u zhenschin s papillomavirusnoj infektsiej v sochetanii s bakterial'nym vaginozom / L. V. Kuklina, E. N. Kravchenko, M. I. Sosin. E. A. Zadorozhnaya // Mat' i ditya v Kuzbasse. – 2018. – № 1(72). – S. 71–76. [Features of the course of pregnancy, childbirth, the postpartum period and the state of newborns in women with papillomovirus infection in combination with bacterial vaginosis. / L. V. Kuklina, E. N. Kravchenko, M. I. Sosnin, E. A. Zadorozhnaya. // Mother and child in Kuzbass. – 2018. – N.1 (72). – p. 71–76].
2. Puzyreva L. V. Geneticheskij polimorfizm tsitokinov: proshloe i buduschee / L. V. Puzyreva, A. D. Safonov // Infektsiya i immunitet. – 2016. – T. 6 – № 2. – S. 103–108. [Puzyryova L. V., Safonov A. D. Cytokines genetic polymorphism: the past and the future // Russian Journal of Infection and Immunity = Infektsiya i immunitet. – 2016. – Vol. 6. – N. 2. – p. 103–108. doi: 10.15789/2220–7619–20162–103–108].
3. Interferon lambda 1 expression in cervical cells differs between low-risk and high-risk human papillomavirus-positive women. / F. Cannella, C. Scagnolari, C. Selvaggi, P. Stentella, N. Recine, G. Antonelli, A. Pierangeli. // Med Microbiol Immunol. – 2014. – Vol.203. – I.3. – P. 177–184. – doi: 10.1007/s00430–014–0330–9.
4. Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. / M. J. Lace, J. R. Anson, A. J. Klingelhutz, H. Harada, T. Taniguchi, A. D. Bossler, T. H. Haugen, L. P. Turek. // Carcinogenesis. – 2009. – Vol.30. – N.8. – P. 1336–1344. – doi:10.1093/carcin/bgp150.
5. The Impact of Interferon Lambda 3 Gene Polymorphism on Natural Course and Treatment of Hepatitis C. / F. Bellanti, G. Vendemiale, E. Altomare, G. Serviddio. // Clinical and Developmental Immunology. – 2012. – Vol.2012. – P. 1–9. – https://doi.org/10.1155/2012/849373.